2017
DOI: 10.3174/ajnr.a5322
|View full text |Cite
|
Sign up to set email alerts
|

Basal Ganglia T1 Hyperintensity in Hereditary Hemorrhagic Telangiectasia

Abstract: Basal ganglia T1 hyperintensity occurs in >23% of patients with hereditary hemorrhagic telangiectasia and is associated with hepatic vascular malformations, hepatic dysfunction, and elevated cardiac output. The presence of this finding on screening MR imaging in patients with hereditary hemorrhagic telangiectasia should prompt further evaluation for visceral lesions causing arteriovenous shunting.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(12 citation statements)
references
References 15 publications
0
12
0
Order By: Relevance
“…No significant association was noted with sex, the genetic mutation status, or parkinsonism (2). Basal ganglia hyperintensity may be a clue suggesting a diagnosis of hepatic encephalopathy, including portosystemic encephalopathy, in clinical practice (2)(3)(4).…”
mentioning
confidence: 86%
See 4 more Smart Citations
“…No significant association was noted with sex, the genetic mutation status, or parkinsonism (2). Basal ganglia hyperintensity may be a clue suggesting a diagnosis of hepatic encephalopathy, including portosystemic encephalopathy, in clinical practice (2)(3)(4).…”
mentioning
confidence: 86%
“…The presence of basal ganglia hyperintensity demonstrated a significant association with increased age, the presence of hepatic AVMs, hepatic telangiectasias, nasal telangiectasias, increased peak cardiac output, hepatic failure, and elevated peak serum alkaline phosphatase levels and elevated total bilirubin levels (2). No significant association was noted with sex, the genetic mutation status, or parkinsonism (2). Basal ganglia hyperintensity may be a clue suggesting a diagnosis of hepatic encephalopathy, including portosystemic encephalopathy, in clinical practice (2)(3)(4).…”
mentioning
confidence: 91%
See 3 more Smart Citations